Cargando…
Anti-cancer Therapy Leads to Increased Cardiovascular Susceptibility to COVID-19
Anti-cancer treatment regimens can lead to both acute- and long-term myocardial injury due to off-target effects. Besides, cancer patients and survivors are severely immunocompromised due to the harsh effect of anti-cancer therapy targeting the bone marrow cells. Cancer patients and survivors can th...
Autores principales: | Lozahic, Caroline, Maddock, Helen, Sandhu, Hardip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102732/ https://www.ncbi.nlm.nih.gov/pubmed/33969006 http://dx.doi.org/10.3389/fcvm.2021.634291 |
Ejemplares similares
-
Cardiovascular Impairment in COVID-19: Learning From Current Options for Cardiovascular Anti-Inflammatory Therapy
por: Wang, Lun, et al.
Publicado: (2020) -
Building the case for mitochondrial transplantation as an anti-aging cardiovascular therapy
por: Headley, Colwyn A., et al.
Publicado: (2023) -
Cardiovascular Complications of COVID-19 Vaccines
por: Liu, Runyu, et al.
Publicado: (2022) -
Androgen Deprivation Therapy in Patients With Prostate Cancer Increases Serum Levels of Thromboxane A(2): Cardiovascular Implications
por: Álvarez-Maestro, Mario, et al.
Publicado: (2021) -
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO)
por: Polverino, Francesca, et al.
Publicado: (2020)